Take Solutions Ltd.

TAKE

₹8.39

-1.99% (-0.17)

Market Cap

₹129 Cr.

P/E

0.00

About

Take Solutions Limited delivers domain-intensive services in Life Sciences and Supply Chain Management. The company offers clients a unique combination of full service Clinical, Regulatory and Safety … Read more

Take Solutions Limited delivers domain-intensive services in Life Sciences and Supply Chain Ma… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Custom financial statementNew

Edit rows

In Rs. Cr.	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024

In Rs. Cr.	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Balance sheet
Net Block	543	554	589	1,091	1,234	934	101	73.20	30.25	0.08
Shareholders Funds	631	911	1,328	1,518	1,575	1,125	181	109	-8.87	-14.17
Profit & Loss
Operating Profit	164	262	306	383	169	-73.03	10.10	-19.04	-13.47	—
Net Sales	1,030	1,345	1,587	2,039	2,213	774	653	189	65.61	—
Cash flow
Cash from Operating Activity	148	55.90	121	104	211	135	120	20.02	9.32	9.69
Net Capex (est)	63.25	86.23	82.05	126	158	1.79	31.21	7.30	7.81	1.04
Ratios
ROCE (%)	20.73	18.15	14.64	14.97	1.57	-13.55	-4.54	-22.71	607	—
ROE (%)	18.95	15.71	12.08	11.68	-0.78	-40.19	-432	-92.32	1,348	—

Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
Working Capital

Working capital of the company seems to be under control
ROE

Financial leverage has increased roe over 10 years
Share price

Share price has decreased over last 10 years more due to earnings
Debt

Company might have issues servicing its debt
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Balance Sheet Strength

Balance sheet is weak and might have solvency issues
Current vs Historic Valuation

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Verticals

Operating Profit Break-Up

Operational Metrics

Net Sales by Employee Cost (.)

Take Solutions Ltd.

Net Sales by Employee Cost (.)
Source

Peer Comparison

Peer Name	Latest Price	PE	Market cap(Cr)	Prom Holding(%)	YoY Qtly Sales(%)	ROCE (%)	ROE (%)
Take Solutions	8.56	0.00	129	53.41	—	606.81	1,348.13
CG-VAK Soft.&Exports	252	13.68	127	53.87	5.15	19.82	14.77
Olatech Solutions	274.4	28.8	122	62.72	—	54.85	40.84
Xelpmoc Design	97.27	0.00	143	52.19	-26.9	-17.38	-22.37
Sagarsoft (India)	153.05	15.95	98	51.36	-12.16	16.1	12.25
GSS Infotech	34.96	14.74	91	12.71	-50.35	0.54	2.13
Securekloud Tech.	26.21	0.00	89	43.52	-53.44	-336.13	604.9
Intrasoft Tech	109.97	14.2	180	43.06	7.03	7.42	4.64

Corporate Actions

Consolidated Dividend

DATE

DETAILS

2019, Aug 01

Dividend Dividend of Rs.0.4 per share

2019, Feb 22

Dividend Dividend of Rs.0.3 per share

2018, Nov 09

Dividend Dividend of Rs.0.3 per share

2018, Aug 02

Dividend Dividend of Rs.0.6 per share

2018, Aug 02

Dividend Dividend of Rs.0.4 per share

Customers

Abbott India Ltd.
Alembic Pharmaceuticals Ltd.
Astrazeneca Pharma India Ltd.
Cipla Ltd.
Dr. Reddy's Laboratories Ltd.
Glenmark Pharmaceuticals Ltd.
Ipca Laboratories Ltd.
Procter & Gamble Health Ltd.
Natco Pharma Ltd.
Novartis India Ltd.
Pfizer Ltd.
Sanofi India Ltd.
Zydus Wellness Ltd.
BITS Ltd.
Allergan
ALS Pharmaceuticals
Amgen
Astellas
Bristol-Myers Squibb
Celgene
Daewoong
Eisai Pharmaceuticals
Fresenius Kabi
Hetero Pharmaceuticals
Johnson & Johnson
Meda Pharmaceuticals
Mylan
Novo Nordisk
Roche
Samsung
Teva Pharmaceutical Industries Limited

Showing 5 of 31

FAQs on Take Solutions Ltd. Business

What does Take Solutions do?

Take Solutions Limited provides full-service Clinical, Regulatory, and Safety services along with unique technology expertise in Life Sciences and Supply Chain Management. They offer services from clinical trials to post-marketing strategy.

Who are the competitors of Take Solutions?

Take Solutions major competitors are CG-VAK Soft.&Exports, Olatech Solutions, Xelpmoc Design, Sagarsoft (India), GSS Infotech, Securekloud Tech., Intrasoft Tech.
Market Cap of Take Solutions is ₹129 Crs.
While the median market cap of its peers are ₹122 Crs.

Is Take Solutions financially stable compared to its competitors?

Take Solutions seems to be less financially stable compared to its competitors.
Altman Z score of Take Solutions is -0.44 and is ranked 8 out of its 8 competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release							Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation					Mar Jun Sep	Mar Jun Sep					Dec
Conference Call					Mar Jun	Jun Sep Dec	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep					Sep
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Take Solutions Ltd.

View the discussion on ValuePickr

A Primer on Cloud Computing - Medium

Analysis Framework for IT Service companies - Dr Vijay Malik

IT Services & The API Economy - PPFAS

In-depth analysis of $200bn IT sector from a Superb Analyst - G2G Ajay

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Take Solutions Ltd.